Primary Endoluminal Techniques for Weight Loss

  • Joseph A. Talarico
  • Stacy A. Brethauer
  • Philip R. Schauer


Though bariatric surgery remains the gold standard in the treatment and management of obesity, endoluminal approaches may offer the potential for significant weight loss with an improved safety and cost profile. Endoluminal therapies can be broadly organized by three approaches: space occupying, malabsorptive, and gastric volume reduction. These combined groups may be safer and more cost-effective compared with traditional operative approaches. For all endoluminal procedures targeted to bariatric surgery, physicians must demand clear outcome measures and well-designed prospective studies. It is imperative that gastroenterologists and bariatric surgeons work together within a multidisciplinary culture and structure to ensure safe adoption of these new techniques. Ultimately, these procedures should be performed within a bariatric program that can provide expert pre- and post-procedure evaluations of the morbidly obese patient.


Bariatric Surgery Excess Weight Loss Gastric Volume BioEnterics Intragastric Balloon Natural Orifice Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    National Health and Nutrition Examination Survey Prevalence of overweight, obesity and extreme obesity among adults: United States, trends 1976–80 through 2005–2006. World Health organization Fact sheet No. 311 Sept 2006.Google Scholar
  2. 2.
    Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who’s paying? Health Aff. 2003;W3:219–26.Google Scholar
  3. 3.
    Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res. 2004;12(1):18–24.PubMedCrossRefGoogle Scholar
  4. 4.
    Nguyen NT. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg. 2005;140(12):1198–202.PubMedCrossRefGoogle Scholar
  5. 5.
    Philip R, Schauer MD, Sayeed Ikramuddin MD, William Gourash CRNP, Ramesh Ramanathan MD, James Luketich MD. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–29.CrossRefGoogle Scholar
  6. 6.
    Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Hawes RH. Transition from laboratory to clinical practice in NOTES: role of NOSCAR. Gastrointest Endosc Clin N Am. 2008;18(2):333–41.PubMedCrossRefGoogle Scholar
  8. 8.
    Hawes R. ASGE/SAGES working group on natural orifice translumenal endoscopic surgery. Gastrointest Endosc. 2006;63:199–203.CrossRefGoogle Scholar
  9. 9.
    Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Fugel et al. Digestive Disease Week (DDW). 2009: Abstract 1426. Presented 2 June 2009.Google Scholar
  11. 11.
    Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis. 2011;8(3):303–4.Google Scholar
  12. 12.
    Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40:406–13.PubMedCrossRefGoogle Scholar
  13. 13.
    Deviere J, Ojeda Valdes G, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc. 2008;22: 589–98.PubMedCrossRefGoogle Scholar
  14. 14.
    Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2008;20(8): 1128–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Genco A, Bruni T, Doldi B, et al. Bioenterics intragastric balloon: the Italian experience with 2515 patients. Obes Surg. 2005;15:1161–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Personal Communication, July 2009.Google Scholar
  17. 17. Clinical Trial Registration. Reshape intragastric balloon for the treatment of obesity (Italy III). 2010. Accessed Apr 2010.
  18. 18.
    Personal Communication, June 2009.Google Scholar
  19. 19.
    Personal Communication, June 2009.Google Scholar
  20. 20.
    Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, et al. A multicenter, randomized efficacy study of the endobarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2009;251(2):236–43.CrossRefGoogle Scholar
  22. 22.
    Innovations in Surgery Presentation May 2009, Cleveland Clinic Foundation, Chris Thompson, MD Presenting, Philip R. Schauer MD, Moderating.Google Scholar
  23. 23.
    Personal Communication, April 2010.Google Scholar
  24. 24.
    The Advisory Board Company, “Bariatric Surgery Volumes 2008–2018”, 2010 Outlook for Bariatric Surgery, 2010.Google Scholar
  25. 25.
    Santry H, Gillen D, Lauderdale D. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909–17.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Joseph A. Talarico
    • 1
  • Stacy A. Brethauer
    • 1
  • Philip R. Schauer
    • 1
  1. 1.Bariatric and Metabolic Institute, Cleveland ClinicClevelandUSA

Personalised recommendations